Enanta Pharmaceuticals(ENTA) - 2026 Q1 - Quarterly Results
Enanta PharmaceuticalsEnanta Pharmaceuticals(US:ENTA)2026-02-09 21:15

Exhibit 99.1 Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025 WATERTOWN, Mass., February 9, 2026 – Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial results for its fiscal first quarter ended December 31, 2025. "Enanta entered the year with significant momentum, advancing our leading RSV treatment portfolio ...